Delgado-Aros et al
The full scope at Ascend includes: Obesity and overweight with comorbidities - full workup, GLP-1 candidacy assessment, lifestyle integration Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously Hypertension tied to weight - coordinated medication review and lifestyle work Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss Prediabetes - HbA1c 5.7-6.4% range, where intervention can prevent progression Fatty liver disease (MASLD) - weight loss is the primary intervention
Analysis of the effects of GLP-1 and GLP-1RAs on cognitive, psychometric, cellular, and molecular changes in preclinical and clinical studies shows that these compounds and drugs modulate the molecular and cellular changes that determine the phenomenology of many brain diseases
Prioritizing lean protein and key nutrients including iron, zinc, vitamin D, and essential fatty acids keeps hair growth strong
The University of Copenhagen, where the analysis occurred, and Statistics Denmark (project number 707278) hold utilization data approval from the Regional Capital Area Data Protection Agency
